Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis

British Journal of Dermatology

Volumn 139, Issue 4, 1998, Pages 675-678

  Barnetson, R St C ^a   Marley, J ^b   Bullen, M ^c   Brookman, S ^d   Cowen, P ^e   Ellis, D ^f   Williams, T ^g  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

^f WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^g NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; TERBINAFINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGUS CULTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TINEA PEDIS; TOPICAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; AUSTRALIA; CLOTRIMAZOLE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPIDERMOPHYTON; HUMANS; NAPHTHALENES; OINTMENTS; PROSPECTIVE STUDIES; TINEA PEDIS; TRICHOPHYTON;

EID: 0031710659     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02466.x     Document Type: Article

References (11)

1. Bergstresser PR, Elewski B, Hanifin J et al. Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicentre comparison of cure and relapse rates with 1- and 4-week treatment regimes. J Am Acad Dermatol 1993; 28: 648-51.
2. Petranyi G, Ryder NS, Stutz A. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 1984; 224: 1239-41.
3. Ryder NS. Specific inhibition of fungal sterol biosynthesis by SF86-327, a new allylamine antimycotic agent. Antimicrob Agents Chemother 1984; 27: 252-6.
4. Ryder NS. The mechanism of action of terbinafine. Clin Exp Dermatol 1989; 14: 98-100.
5. Petranyi G, MeinGasser JG, Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother 1987; 31: 1365-8.
6. Clayton Y. In vitro activity of terbinafine. Clin Exp Dermatol 1989; 14: 101-3.
7. Goodfield MJ, Andrew L, Evans EG. Short term treatment of dermatophyte onychomycosis with terbinafine. Br Med J 1992; 304: 1151-4.
8. Brautigam M, Nolting S, Schopf RE, Weidinger G. Randomised double blind comparison of terbinafine and itraconazole for the treatment of toenail tinea infection. Br Med J 1995; 311: 919-22.
9. White JE, Perkins PJ, Evans EG. Successful 2-week treatment with terbinafine (Lamisil) for moccasin tinea pedis and tinea manuum. Br J Dermatol 1991; 125: 260-2.
10. Farag A, Taha M, Halim S. One week therapy with oral terbinafine in cases of tinea cruris/corporis. Br J Dermatol 1994; 131: 684-6.
11. Evans EGV, James IGV, Joshipura RC. Two-week treatment of tinea pedis with terbinafine (Lamisil) 1% cream: a placebo controlled study. J Dermatol Treatment 1991; 2: 95-7.